title: Treatment of neurosarcoidosis--innovations and challenges.
abstract: BACKGROUND
  Sarcoidosis affects the central nervous system more frequently than it used to be believed. While the cranial nerves are most frequently affected, neurosarcoidosis can involve other nervous system tissues as well. TREATMENT OF NEUROSARCOIDOSIS: Although a lot of drugs have proved useful in treating neurosarcoidosis, corticosteroids are still the gold standard in treatment of these patients. Therapeutic protocols differ regarding the dose of these drugs. Symptomatic neurosarcoidosis should always be treated with pulse corticosteroid therapy. People with diabetes, high blood pressure, osteoporosis and tuberculosis should be carefully monitored, as they are prone to complications associated with treatment with corticosteroids. In cases when treatment with corticosteroids does not show the desired results or therapy is discontinued due to the development of side effects, there are other pharmacologic options, such as methotrexate, mycophenolate mofetil, cyclophosphamide, chloroquine, azathioprine, thalidomide, and infliximab. It should be noted that the treatment response to the above mentioned regimens, except for infliximab, is relatively slow compared to corticosteroids; therefore, corticosteroids should be taken into account in all states and particularly in the acute phase of the disease.
  
  
  CONCLUSIONS
  It is the existence of different forms of the disease, lack of local diagnostic criteria and different and non standardized therapy that makes the treatment of this disease difficult. Despite advances in pharmacotherapy and radiological diagnosis, it is necessary to develop better diagnostic strategies in order to set the optimal therapeutic approach.
authors.forename: Mihailo I
authors.initials: MI
authors.lastname: Stjepanović
authors.forename: Violeta Mihailović
authors.initials: VM
authors.lastname: Vucinić
authors.forename: Dragana
authors.initials: D
authors.lastname: Jovanović
authors.forename: Milija
authors.initials: M
authors.lastname: Mijajlović
authors.forename: Vesna Skodrić
authors.initials: VS
authors.lastname: Trifunović
authors.forename: Mirjana M
authors.initials: MM
authors.lastname: Stjepanović
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D001921:Brain / Q000503:physiopathology; D002493:Central Nervous System Diseases / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D020551:Pulse Therapy, Drug; D012507:Sarcoidosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D000305:Adrenal Cortex Hormones; D005938:Glucocorticoids; D007166:Immunosuppressive Agents